Lymphoma Working Party (LWP)
Type d'étude:
Numéro de l'étude:
2009-N-02
Type de traitement à base de cellules souches:
Maladies:
Other myeloid or lymphoid malignancies
Titre court:
NIS BPDCN
Objectif principal:
Principaux critères d'inclusion:
Patients submitted for allo or auto SCT with diagnosis of BPDC as proven by state-of-the-art histological, cytological, immunophenotypical, genetical and/or molecular diagnostic work-up.
Pays:
Investigateur principal:
Sascha Dietrich, Peter Dreger
Coordinateur EBMT de l'étude:
Hervé Finel